Stock Comparison
GILD vs LLY
Gilead Sciences Inc and Eli Lilly and Company side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$158.77B
$1.08T
P/E (TTM)
17.4
42.9
Forward P/E
15.2
31.1
Price/Sales
5.3
14.9
Price/Book
6.8
32.2
EV/EBITDA
12.0
28.8
Dividend Yield
2.58%
0.55%
Profitability
Net Margin
31.00%
35.00%
Operating Margin
39.30%
49.40%
Return on Equity
43.40%
107.50%
Return on Assets
13.30%
20.70%
Growth (YoY)
Revenue Growth
4.40%
55.50%
Earnings Growth
54.80%
169.90%
Price & Risk
Beta
0.3
0.5
52-Week High
$155.38
$1,215.76
52-Week Low
$105.01
$619.40
Analyst Target
$157.57
$1,222.62
Compare GILD and LLY your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.